Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Features

General Jurisdiction After <i>Daimler AG v. Bauman</i> Image

General Jurisdiction After <i>Daimler AG v. Bauman</i>

James H. Rotondo, John W. Cerreta & David W.S. Lieberman

Often, when patients are injured by pharmaceutical products, the plaintiff and the product's manufacturer are located in different jurisdictions, making jurisdictional questions the first issue to resolve when choosing where to file suit. In 2014, the Supreme Court's decision in <I>Daimler AG v. Bauman</I>announced a sweeping change to the law of personal jurisdiction.

Features

The Famous Dr. DeBakey and His Two Controversial Practices Image

The Famous Dr. DeBakey and His Two Controversial Practices

Edward D. McCarthy

As we noted last month, cardiac surgeon Michael DeBakey performed "overlapping surgeries," in which he moved from one operating room to another; and 2) He filmed many, if not all, of his procedures. Both of these practices have potential to impact the outcome of a medical malpractice claim.

Columns & Departments

Med Mal News Image

Med Mal News

In March, Arizona became the first state to undercut the FDA's new guidelines on use of the abortion-inducing drug Mifepristone.

The Famous Dr. DeBakey and His Two Controversial Practices Image

The Famous Dr. DeBakey and His Two Controversial Practices

Edward D. McCarthy

Recently, there has been a great deal of press, as well as litigation, involving two things: so-called "overlapping surgery," and requests by patients to record their encounters with their physicians and with their surgical procedures. Many years ago, a world-famous cardiac surgeon, at least anecdotally, did both things.

Columns & Departments

Verdicts Image

Verdicts

In-depth analysis of a case involving a deceased patient's medical records.

Features

Trio of Plaintiffs' Verdicts in Risperdal Litigation Present Significant Issues for Johnson & Johnson Image

Trio of Plaintiffs' Verdicts in Risperdal Litigation Present Significant Issues for Johnson & Johnson

Michael D. Brophy

A series of three verdicts for plaintiffs, the most recent in December 2015, may present significant litigation issues for Johnson &amp; Johnson and its subsidiary, Janssen Pharmaceuticals. The suits were all based upon claims that the manufacturer failed to provide adequate warnings regarding Risperdal gynecomastia ' a condition that involves abnormally enlarged male breast tissue, especially among adolescent boys.

Columns & Departments

Med Mal News Image

Med Mal News

Review of a case in which another health care worker was indicted for stealing opioids at work.

Proper Objections at a Personal Injury Deposition Image

Proper Objections at a Personal Injury Deposition

Kevin G. Faley & Andrea M. Alonso

When asserting the doctor-patient privilege, a witness cannot refuse to reveal medical incidents or facts once the witness has put the medical condition in controversy. Often, in a personal injury case, the plaintiff has already put a specific injury at issue by filing the lawsuit.

Drug & Device News Image

Drug & Device News

A look at the latest news and developments.

Columns & Departments

Med Mal News Image

Med Mal News

Professional Association's Censure Not Actionable in Courts

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • The Roadmap of Litigation Analytics
    Litigation analytics can be considered a roadmap of sorts — an important guide to ensure the legal professional arrives at the correct litigation strategy or business plan. However, like roadmaps, litigation analytics will only be useful if it's based on data that is complete and accurate.
    Read More ›
  • Understanding the Potential Pitfalls Arising From Participation in Standards Bodies
    Chances are that if your company is involved in research and development of new technology there is a standards setting organization exploring the potential standardization of such technology. While there are clear benefits to participation in standards organizations &mdash; keeping abreast of industry developments, targeting product development toward standard compliant products, steering research and intellectual property protection into potential areas of future standardization &mdash; such participation does not come without certain risks. Whether you are in-house counsel or outside counsel, you may be called upon to advise participants in standard-setting bodies about intellectual property issues or to participate yourself. You may also be asked to review patent policy of the standard-setting body that sets forth the disclosure and notification requirements with respect to patents for that organization. Here are some potential patent pitfalls that can catch the unwary off-guard.
    Read More ›